{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T14:30:33Z","timestamp":1779114633323,"version":"3.51.4"},"reference-count":55,"publisher":"Elsevier BV","issue":"32","license":[{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000774","name":".S. Defense Threat Reduction Agency","doi-asserted-by":"crossref","award":["HDTRA1-06-CBDIFBAA"],"award-info":[{"award-number":["HDTRA1-06-CBDIFBAA"]}],"id":[{"id":"10.13039\/100000774","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100007680","name":"U.S. Naval Medical Research Center","doi-asserted-by":"crossref","award":["NCRADA-NMR06-2515"],"award-info":[{"award-number":["NCRADA-NMR06-2515"]}],"id":[{"id":"10.13039\/100007680","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1016\/j.vaccine.2012.04.078","type":"journal-article","created":{"date-parts":[[2012,5,23]],"date-time":"2012-05-23T18:13:24Z","timestamp":1337796804000},"page":"4872-4883","source":"Crossref","is-referenced-by-count":20,"title":["Electroporation of a multivalent DNA vaccine cocktail elicits a protective immune response against anthrax and plague"],"prefix":"10.1016","volume":"30","author":[{"given":"Mark T.","family":"Albrecht","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian D.","family":"Livingston","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John T.","family":"Pesce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matt G.","family":"Bell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Drew","family":"Hannaman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea M.","family":"Keane-Myers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.vaccine.2012.04.078_bib0005","doi-asserted-by":"crossref","first-page":"719","DOI":"10.2165\/00019053-200422110-00003","article-title":"Economic aspects of pneumococcal pneumonia: a review of the literature","volume":"22","author":"De Graeve","year":"2004","journal-title":"Pharmacoeconomics"},{"issue":"8","key":"10.1016\/j.vaccine.2012.04.078_bib0010","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/0264-410X(91)90237-Z","article-title":"Anthrax vaccines: past, present and future","volume":"9","author":"Turnbull","year":"1991","journal-title":"Vaccine"},{"issue":"RR-15","key":"10.1016\/j.vaccine.2012.04.078_bib0015","first-page":"1","article-title":"Use of anthrax vaccine in the United States: recommendations of the Advisory Committee on Immunization Practices","volume":"49","author":"C.D.C.","year":"2000","journal-title":"MMWR"},{"issue":"1","key":"10.1016\/j.vaccine.2012.04.078_bib0020","first-page":"75","article-title":"Measurement of protective serum antibodies in human volunteers inoculated with plague prophylactics","volume":"6","author":"Meyer","year":"1948","journal-title":"Stanford Med Bull"},{"issue":"12","key":"10.1016\/j.vaccine.2012.04.078_bib0025","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1586\/erv.09.129","article-title":"Prospects for new plague vaccines","volume":"8","author":"Feodorova","year":"2009","journal-title":"Expert Rev Vaccines"},{"issue":"11","key":"10.1016\/j.vaccine.2012.04.078_bib0030","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1093\/milmed\/138.11.720","article-title":"Clinical and serological responses to plague vaccine U.S.P.","volume":"138","author":"Bartelloni","year":"1973","journal-title":"Mil Med"},{"issue":"1","key":"10.1016\/j.vaccine.2012.04.078_bib0035","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1128\/AEM.22.1.84-88.1971","article-title":"Immunogenicity of plague vaccines in mice and guinea pigs","volume":"22","author":"von Metz","year":"1971","journal-title":"Appl Microbiol"},{"issue":"3","key":"10.1016\/j.vaccine.2012.04.078_bib0040","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.coi.2011.03.008","article-title":"Electroporation delivery of DNA vaccines: prospects for success","volume":"23","author":"Sardesai","year":"2011","journal-title":"Curr Opin Immunol"},{"issue":"11","key":"10.1016\/j.vaccine.2012.04.078_bib0045","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1517\/14712598.7.11.1647","article-title":"Electroporation-based DNA immunisation: translation to the clinic","volume":"7","author":"Luxembourg","year":"2007","journal-title":"Expert Opin Biol Ther"},{"issue":"5-6","key":"10.1016\/j.vaccine.2012.04.078_bib0050","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0020-7519(03)00056-0","article-title":"Technical and regulatory hurdles for DNA vaccines","volume":"33","author":"Donnelly","year":"2003","journal-title":"Int J Parasitol"},{"issue":"10","key":"10.1016\/j.vaccine.2012.04.078_bib0055","doi-asserted-by":"crossref","first-page":"7462","DOI":"10.4049\/jimmunol.177.10.7462","article-title":"Modulation of the immune response induced by gene electrotransfer of a hepatitis C virus DNA vaccine in nonhuman primates","volume":"177","author":"Capone","year":"2006","journal-title":"J Immunol"},{"issue":"5","key":"10.1016\/j.vaccine.2012.04.078_bib0060","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1128\/CVI.00030-11","article-title":"A DNA vaccine for Venezuelan equine encephalitis virus delivered by intramuscular electroporation elicits high levels of neutralizing antibodies in multiple animal models and provides protective immunity to mice and nonhuman primates","volume":"18","author":"Dupuy","year":"2011","journal-title":"Clin Vaccine Immunol"},{"issue":"10","key":"10.1016\/j.vaccine.2012.04.078_bib0065","doi-asserted-by":"crossref","first-page":"5257","DOI":"10.1128\/JVI.00055-07","article-title":"Effect of plasmid DNA vaccine design and in vivo electroporation on the resulting vaccine-specific immune responses in rhesus macaques","volume":"81","author":"Luckay","year":"2007","journal-title":"J Virol"},{"issue":"21","key":"10.1016\/j.vaccine.2012.04.078_bib0070","doi-asserted-by":"crossref","first-page":"4490","DOI":"10.1016\/j.vaccine.2005.08.014","article-title":"Enhancement of immune responses to an HBV DNA vaccine by electroporation","volume":"24","author":"Luxembourg","year":"2006","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.vaccine.2012.04.078_bib0075","doi-asserted-by":"crossref","first-page":"4635","DOI":"10.4049\/jimmunol.164.9.4635","article-title":"Increased DNA vaccine delivery and immunogenicity by electroporation in vivo","volume":"164","author":"Widera","year":"2000","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2012.04.078_bib0080","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.vaccine.2009.10.111","article-title":"Comparative performance of a licensed anthrax vaccine versus electroporation based delivery of a PA encoding DNA vaccine in rhesus macaques","volume":"28","author":"Livingston","year":"2010","journal-title":"Vaccine"},{"issue":"40","key":"10.1016\/j.vaccine.2012.04.078_bib0085","doi-asserted-by":"crossref","first-page":"5216","DOI":"10.1016\/j.vaccine.2008.03.064","article-title":"Potentiation of an anthrax DNA vaccine with electroporation","volume":"26","author":"Luxembourg","year":"2008","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2012.04.078_bib0090","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1016\/j.vaccine.2009.10.059","article-title":"Antigen engineering can play a critical role in the protective immunity elicited by Yersinia pestis DNA vaccines","volume":"28","author":"Wang","year":"2010","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2012.04.078_bib0095","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.biotechadv.2009.02.003","article-title":"Plasmid DNA vaccine vector design: impact on efficacy, safety and upstream production","volume":"27","author":"Williams","year":"2009","journal-title":"Biotechnol Adv"},{"issue":"11","key":"10.1016\/j.vaccine.2012.04.078_bib0100","doi-asserted-by":"crossref","first-page":"5425","DOI":"10.1128\/IAI.00261-07","article-title":"Human monoclonal antibodies against anthrax lethal factor and protective antigen act independently to protect against Bacillus anthracis infection and enhance endogenous immunity to anthrax","volume":"75","author":"Albrecht","year":"2007","journal-title":"Infect Immun"},{"issue":"7","key":"10.1016\/j.vaccine.2012.04.078_bib0105","doi-asserted-by":"crossref","first-page":"4509","DOI":"10.1128\/IAI.69.7.4509-4515.2001","article-title":"Protection against anthrax lethal toxin challenge by genetic immunization with a plasmid encoding the lethal factor protein","volume":"69","author":"Price","year":"2001","journal-title":"Infect Immun"},{"issue":"6","key":"10.1016\/j.vaccine.2012.04.078_bib0110","doi-asserted-by":"crossref","first-page":"3734","DOI":"10.1128\/IAI.73.6.3734-3739.2005","article-title":"Protein microarray for profiling antibody responses to Yersinia pestis live vaccine","volume":"73","author":"Li","year":"2005","journal-title":"Infect Immun"},{"issue":"12","key":"10.1016\/j.vaccine.2012.04.078_bib0115","doi-asserted-by":"crossref","first-page":"4538","DOI":"10.4049\/jimmunol.136.12.4538","article-title":"B cell stimulatory factor-1 enhances the IgE response of lipopolysaccharide-activated B cells","volume":"136","author":"Coffman","year":"1986","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2012.04.078_bib0120","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1084\/jem.155.3.734","article-title":"T cell-derived B cell differentiation factor(s). Effect on the isotype switch of murine B cells","volume":"155","author":"Isakson","year":"1982","journal-title":"J Exp Med"},{"issue":"4804","key":"10.1016\/j.vaccine.2012.04.078_bib0125","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1126\/science.3107127","article-title":"Interferon-gamma and B cell stimulatory factor-1 reciprocally regulate Ig isotype production","volume":"236","author":"Snapper","year":"1987","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.vaccine.2012.04.078_bib0130","doi-asserted-by":"crossref","first-page":"3598","DOI":"10.1128\/IAI.73.6.3598-3608.2005","article-title":"Human immune response to a plague vaccine comprising recombinant F1 and V antigens","volume":"73","author":"Williamson","year":"2005","journal-title":"Infect Immun"},{"issue":"3","key":"10.1016\/j.vaccine.2012.04.078_bib0135","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1046\/j.1462-5822.2003.00358.x","article-title":"Systemic cytokine response in murine anthrax","volume":"6","author":"Popov","year":"2004","journal-title":"Cell Microbiol"},{"issue":"6","key":"10.1016\/j.vaccine.2012.04.078_bib0140","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1128\/IAI.01875-06","article-title":"Murine aerosol challenge model of anthrax","volume":"75","author":"Loving","year":"2007","journal-title":"Infect Immun"},{"issue":"3","key":"10.1016\/j.vaccine.2012.04.078_bib0145","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1128\/IAI.51.3.795-800.1986","article-title":"Differences in susceptibility of inbred mice to Bacillus anthracis","volume":"51","author":"Welkos","year":"1986","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2012.04.078_bib0150","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1146\/annurev.iy.07.040189.001045","article-title":"TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties","volume":"7","author":"Mosmann","year":"1989","journal-title":"Annu Rev Immunol"},{"issue":"7","key":"10.1016\/j.vaccine.2012.04.078_bib0155","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.4049\/jimmunol.136.7.2348","article-title":"Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins","volume":"136","author":"Mosmann","year":"1986","journal-title":"J Immunol"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2012.04.078_bib0160","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.1016\/j.jcpa.2007.04.014","article-title":"The nature and consequences of intra- and inter-vaccine interference","volume":"137","author":"Vidor","year":"2007","journal-title":"J Comp Pathol"},{"issue":"5","key":"10.1016\/j.vaccine.2012.04.078_bib0165","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/sj.gt.3302139","article-title":"Reduced immunogenicity of DNA vaccine plasmids in mixtures","volume":"11","author":"Sedegah","year":"2004","journal-title":"Gene Ther"},{"issue":"1","key":"10.1016\/j.vaccine.2012.04.078_bib0170","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.virol.2009.07.035","article-title":"Interference of porcine circovirus type 2 ORF2 immunogenicity by ORF1 and ORF3 mixed DNA immunizations in mice","volume":"393","author":"Shen","year":"2009","journal-title":"Virology"},{"issue":"22","key":"10.1016\/j.vaccine.2012.04.078_bib0175","doi-asserted-by":"crossref","first-page":"4429","DOI":"10.1016\/j.vaccine.2007.03.023","article-title":"Combined DNA vaccination against three animal viruses elicits decreased immunogenicity of a single plasmid in mice","volume":"25","author":"Wang","year":"2007","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2012.04.078_bib0180","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/eji.200838058","article-title":"Anthrax protective antigen administered by DNA vaccination to distinct subcellular locations potentiates humoral and cellular immune responses","volume":"39","author":"Midha","year":"2009","journal-title":"Eur J Immunol"},{"issue":"23","key":"10.1016\/j.vaccine.2012.04.078_bib0185","doi-asserted-by":"crossref","first-page":"4586","DOI":"10.1016\/j.vaccine.2007.03.051","article-title":"A new vaccine adjuvant (BOS 2000) a potent enhancer mixed Th1\/Th2 immune responses in mice immunized with HBsAg","volume":"25","author":"Khajuria","year":"2007","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2012.04.078_bib0190","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1046\/j.1365-2672.1999.00897.x","article-title":"In vitro correlate of immunity in an animal model of inhalational anthrax","volume":"87","author":"Pitt","year":"1999","journal-title":"J Appl Microbiol"},{"issue":"5","key":"10.1016\/j.vaccine.2012.04.078_bib0195","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1128\/CVI.00398-06","article-title":"Development of in vitro correlate assays of immunity to infection with Yersinia pestis","volume":"14","author":"Bashaw","year":"2007","journal-title":"Clin Vaccine Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2012.04.078_bib0200","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1586\/14760584.7.2.209","article-title":"Current challenges in the development of vaccines for pneumonic plague","volume":"7","author":"Smiley","year":"2008","journal-title":"Expert Rev Vaccines"},{"issue":"5","key":"10.1016\/j.vaccine.2012.04.078_bib0205","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.4049\/jimmunol.178.5.2646","article-title":"IFN-gamma-producing CD4T lymphocytes mediate spore-induced immunity to capsulated Bacillus anthracis","volume":"178","author":"Glomski","year":"2007","journal-title":"J Immunol"},{"issue":"Pt 3","key":"10.1016\/j.vaccine.2012.04.078_bib0210","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1099\/13500872-142-3-707","article-title":"Characterization of lethal factor binding and cell receptor binding domains of protective antigen of Bacillus anthracis using monoclonal antibodies","volume":"142","author":"Little","year":"1996","journal-title":"Microbiology"},{"issue":"1","key":"10.1016\/j.vaccine.2012.04.078_bib0215","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1046\/j.1365-2249.1999.00859.x","article-title":"An IgG1 titre to the F1 and V antigens correlates with protection against plague in the mouse model","volume":"116","author":"Williamson","year":"1999","journal-title":"Clin Exp Immunol"},{"issue":"5","key":"10.1016\/j.vaccine.2012.04.078_bib0220","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.4049\/jimmunol.158.5.2278","article-title":"T helper cell types and antibody isotypes generated by saline and gene gun DNA immunization","volume":"158","author":"Feltquate","year":"1997","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2012.04.078_bib0225","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/S0264-410X(98)00210-2","article-title":"Protection against anthrax toxin by vaccination with a DNA plasmid encoding anthrax protective antigen","volume":"17","author":"Gu","year":"1999","journal-title":"Vaccine"},{"issue":"4949 Pt 1","key":"10.1016\/j.vaccine.2012.04.078_bib0230","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1126\/science.1690918","article-title":"Direct gene transfer into mouse muscle in vivo","volume":"247","author":"Wolff","year":"1990","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.vaccine.2012.04.078_bib0235","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.vaccine.2010.11.011","article-title":"Immunogenicity, safety, biodistribution and persistence of ADVAX, a prophylactic DNA vaccine for HIV-1, delivered by in vivo electroporation","volume":"29","author":"Dolter","year":"2011","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2012.04.078_bib0240","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/sj.gt.3302213","article-title":"Detection of integration of plasmid DNA into host genomic DNA following intramuscular injection and electroporation","volume":"11","author":"Wang","year":"2004","journal-title":"Gene Ther"},{"issue":"5","key":"10.1016\/j.vaccine.2012.04.078_bib0280","doi-asserted-by":"crossref","first-page":"e19252","DOI":"10.1371\/journal.pone.0019252","article-title":"In vivo electroporation enhances the immunogenicity of an HIV-1 DNA vaccine candidate in healthy volunteers","volume":"6","author":"Vasan","year":"2011","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.vaccine.2012.04.078_bib0250","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1002\/1521-4141(2000)30:8<2333::AID-IMMU2333>3.0.CO;2-F","article-title":"Characterization of MHC class II-presented peptides generated from an antigen targeted to different endocytic compartments","volume":"30","author":"Fernandes","year":"2000","journal-title":"Eur J Immunol"},{"issue":"3\u20134","key":"10.1016\/j.vaccine.2012.04.078_bib0255","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1574-695X.1995.tb00196.x","article-title":"A new improved sub-unit vaccine for plague: the basis of protection","volume":"12","author":"Williamson","year":"1995","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"11\u201312","key":"10.1016\/j.vaccine.2012.04.078_bib0260","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/S0264-410X(98)80110-2","article-title":"Protection against experimental bubonic and pneumonic plague by a recombinant capsular F1-V antigen fusion protein vaccine","volume":"16","author":"Heath","year":"1998","journal-title":"Vaccine"},{"issue":"23\u201324","key":"10.1016\/j.vaccine.2012.04.078_bib0265","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1016\/S0264-410X(02)00232-3","article-title":"Co-immunisation with a plasmid DNA cocktail primes mice against anthrax and plague","volume":"20","author":"Williamson","year":"2002","journal-title":"Vaccine"},{"issue":"52","key":"10.1016\/j.vaccine.2012.04.078_bib0270","doi-asserted-by":"crossref","first-page":"7436","DOI":"10.1016\/j.vaccine.2009.07.015","article-title":"Protection against anthrax and plague by a combined vaccine in mice and rabbits","volume":"27","author":"Ren","year":"2009","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2012.04.078_bib0275","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.femsim.2004.10.012","article-title":"Protective efficacy of a recombinant plague vaccine when co-administered with another sub-unit or live attenuated vaccine","volume":"43","author":"Griffin","year":"2005","journal-title":"FEMS Immunol Med Microbiol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1200624X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1200624X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,22]],"date-time":"2023-06-22T22:30:57Z","timestamp":1687473057000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X1200624X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7]]},"references-count":55,"journal-issue":{"issue":"32","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["S0264410X1200624X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2012.04.078","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,7]]}}}